Rare Disease Trial, Recruiting NCT06708468 Sponsor: Oslo University Hospital Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT06708468
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a confirmed diagnosis of facioscapulohumeral muscular dystrophy (FSHD), myotonic dystrophy type 1 (DM1), or Charcot-Marie-Tooth disease (CMT)
  • You are between 18 and 70 years old at the time of signing the consent form
  • You are of any gender
  • You are able to stand up, rise from a chair, and walk at least 10 meters, with or without a walking aid
  • A neurologist or physiotherapist has confirmed that you would benefit from rehabilitation
  • You are able to understand and follow instructions in Norwegian
  • You are able to give your own informed consent to take part in the trial

Who may not be able to join:

  • You are pregnant or planning to become pregnant
  • You have another neurological or physical health condition that significantly affects your ability to move or be physically active, such as severe arthritis, serious heart failure, or an ongoing cancer treatment
  • You have a history of alcohol or drug abuse recorded in your medical notes
  • You have a history of not following medical advice or attending medical follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kristin Ørstavik, MD, PhD, Oslo University Hospital

Phone: +4792422126

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 December 2024
Est. completion
1 December 2027

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Dynamic balance assessed using Mini-Balance Evalulation Systems Test (Mini-BESTest)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov